Sensorion Stock OTC Markets
Stocks
SENOF
FR0012596468
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 140M 159M 130M 119M 224M 15.32B 228M 1.54B 603M 7.53B 597M 584M 26.05B | P/E 2026 * |
-18.1x | P/E 2027 * | -4.18x |
|---|---|---|---|---|---|
| Enterprise Value | 7.75M 8.82M 7.2M 6.61M 12.42M 849M 12.61M 85.55M 33.42M 418M 33.11M 32.4M 1.44B | EV / Sales 2026 * |
0.35x | EV / Sales 2027 * | 21.9x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 01/06/2026 |
Laurene Danon
DFI | Director of Finance/CFO | - | 26/06/2024 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 09/03/2015 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 30/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 159M | |
| +1.07% | -3.49% | -3.35% | +10.44% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +634.87% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +65.64% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.16% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +40.92% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.36% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +0.42% | -5.52% | -3.43% | +9.03% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -33.61% | 12.7B | |
| Average | +0.20% | +0.83% | +54.56% | +106.44% | 27.25B | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.42% | +136.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.86M 24.89M 20.33M 18.65M 35.05M 2.4B 35.59M 241M 94.31M 1.18B 93.42M 91.41M 4.07B | 6.4M 7.28M 5.95M 5.46M 10.25M 701M 10.41M 70.62M 27.59M 345M 27.33M 26.74M 1.19B |
| Net income | -4.34M -4.94M -4.04M -3.7M -6.96M -476M -7.07M -47.93M -18.72M -234M -18.55M -18.15M -809M | -50.64M -57.66M -47.09M -43.21M -81.2M -5.55B -82.45M -559M -218M -2.73B -216M -212M -9.44B |
| Net Debt | -132M -150M -123M -113M -212M -14.47B -215M -1.46B -570M -7.12B -564M -552M -24.6B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
- SENOF Stock
Select your edition
All financial news and data tailored to specific country editions
